HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cynthia M Magro Selected Research

Pityriasis Lichenoides (Pityriasis Lichenoides et Varioliformis Acuta)

11/2008Foxp3 expression in cutaneous T-cell lymphocytic infiltrates.
4/2008Assessment of TCR-beta clonality in a diverse group of cutaneous T-Cell infiltrates.
9/2003The utility of the in situ detection of T-cell receptor Beta rearrangements in cutaneous T-cell-dominant infiltrates.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Cynthia M Magro Research Topics

Disease

17Neoplasms (Cancer)
10/2017 - 09/2003
14Lymphoma (Lymphomas)
02/2019 - 07/2006
9Vasculitis (Vasculitides)
12/2017 - 06/2002
7Inflammation (Inflammations)
11/2013 - 04/2006
6Dermatomyositis (Dermatopolymyositis)
11/2020 - 02/2003
6Disease Progression
12/2019 - 11/2002
6Vascular Diseases (Vascular Disease)
02/2019 - 02/2007
6Skin Diseases (Skin Disease)
01/2017 - 08/2007
6Fibrosis (Cirrhosis)
11/2016 - 01/2004
6Dermatitis
08/2011 - 06/2002
6Rheumatoid Arthritis
08/2011 - 02/2003
5COVID-19
02/2021 - 06/2020
5Infections
02/2021 - 01/2003
5Thrombosis (Thrombus)
01/2021 - 11/2013
5Vascular System Injuries
01/2021 - 11/2002
5Malignant Atrophic Papulosis
11/2020 - 11/2002
5Mycosis Fungoides
02/2019 - 04/2010
5B-Cell Lymphoma (Lymphoma, B Cell)
12/2018 - 08/2005
5Hypersensitivity (Allergy)
07/2016 - 03/2003
5Melanoma (Melanoma, Malignant)
09/2014 - 10/2005
5Pulmonary Fibrosis (Fibrosing Alveolitis)
06/2014 - 02/2003
5Idiopathic Pulmonary Fibrosis
06/2014 - 11/2002
5Necrosis
10/2013 - 11/2002
4Pseudolymphoma
07/2018 - 07/2006
4Nevus (Nevi)
06/2017 - 03/2010
4Purpura
10/2013 - 11/2002
4Erythema elevatum diutinum
08/2011 - 11/2002
4Hemorrhage
04/2009 - 11/2002
4Connective Tissue Diseases (Connective Tissue Disease)
01/2008 - 06/2002
3Lymphomatoid Papulosis
07/2018 - 04/2006
3Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2018 - 03/2003
3Hyperplasia
01/2017 - 02/2003
3Thrombotic Microangiopathies
05/2015 - 11/2013
3Pityriasis Lichenoides (Pityriasis Lichenoides et Varioliformis Acuta)
11/2008 - 09/2003
2Atypical Hemolytic Uremic Syndrome
12/2020 - 05/2015
2Amyloidosis
11/2019 - 07/2005
2Alopecia (Baldness)
11/2019 - 12/2011
2Localized Scleroderma (Morphea)
01/2019 - 03/2011
2Lymphoproliferative Disorders (Lymphoproliferative Disorder)
12/2018 - 10/2006
2Carcinoma (Carcinomatosis)
10/2018 - 06/2006
2Exanthema (Rash)
07/2018 - 01/2008
2Polyarteritis Nodosa (Periarteritis Nodosa)
12/2017 - 03/2003
2Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
12/2017 - 07/2017
2T-Cell Lymphoma (Lymphoma, T Cell)
07/2017 - 05/2015
2Psoriasis (Pustulosis Palmaris et Plantaris)
02/2017 - 05/2010
2Diabetes Mellitus
02/2017 - 01/2007
2Crohn Disease (Crohn's Disease)
02/2017 - 07/2006
2Nephrogenic Fibrosing Dermopathy
01/2017 - 09/2008
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2017 - 09/2006
2Thrombotic Thrombocytopenic Purpura
05/2015 - 01/2015
2Calciphylaxis
01/2015 - 05/2002
2Lupus Erythematosus Panniculitis (Panniculitis, Lupus)
05/2013 - 09/2012
2Subcutaneous panniculitis-like T-cell lymphoma
05/2013 - 10/2008

Drug/Important Bio-Agent (IBA)

16Pharmaceutical PreparationsIBA
07/2018 - 01/2003
11Complement System Proteins (Complement)IBA
02/2021 - 03/2003
11CollagenIBA
02/2019 - 06/2002
11AntibodiesIBA
10/2012 - 11/2002
8Proteins (Proteins, Gene)FDA Link
02/2021 - 05/2002
8Complement Membrane Attack Complex (Membrane Attack Complex)IBA
10/2020 - 11/2002
8RNA (Ribonucleic Acid)IBA
06/2014 - 06/2002
6Immunoglobulin A (IgA)IBA
11/2008 - 11/2002
5Rituximab (Mabthera)FDA Link
11/2020 - 10/2005
5MucinsIBA
10/2018 - 04/2004
5AntigensIBA
07/2018 - 11/2005
5ParaffinIBA
01/2015 - 01/2004
5DNA (Deoxyribonucleic Acid)IBA
06/2014 - 06/2002
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2021 - 01/2004
4eculizumabFDA Link
10/2020 - 11/2013
4Methotrexate (Mexate)FDA LinkGeneric
12/2018 - 08/2005
4Phenobarbital (Luminal)FDA Link
12/2017 - 11/2013
4Biological ProductsIBA
10/2012 - 02/2006
4AutoantibodiesIBA
02/2009 - 01/2003
3Interleukin-6 (Interleukin 6)IBA
02/2021 - 01/2017
3CytokinesIBA
02/2021 - 05/2013
3Viral RNAIBA
02/2021 - 06/2020
3Hematoxylin (Haematoxylon)IBA
02/2021 - 10/2005
3Eosine Yellowish-(YS) (Eosin)IBA
02/2021 - 10/2005
3Antiphospholipid AntibodiesIBA
01/2021 - 02/2003
3FibrinIBA
12/2017 - 11/2002
3Interferon Type IIBA
12/2017 - 06/2010
3NAD (NADH)IBA
06/2017 - 03/2010
3Formaldehyde (Formol)FDA Link
01/2015 - 01/2005
3Adenylyl Cyclases (Adenylyl Cyclase)IBA
12/2012 - 05/2010
3Immunoglobulin G (IgG)IBA
02/2009 - 11/2002
3Tuberculin (PPD)IBA
11/2008 - 08/2007
3Immunoglobulins (Immunoglobulin)IBA
11/2008 - 11/2002
3anti-endothelial cell antibodyIBA
01/2008 - 06/2006
2Hydroxyurea (Hydrea)FDA LinkGeneric
05/2022 - 11/2008
2Capsid Proteins (Capsid Protein)IBA
02/2021 - 12/2020
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2020 - 08/2012
2Adrenal Cortex Hormones (Corticosteroids)IBA
11/2020 - 04/2002
2LigandsIBA
01/2018 - 05/2013
2GadoliniumIBA
01/2017 - 09/2008
2Interleukin-17 (Interleukin 17)IBA
06/2014 - 03/2012
2Cocaine (Cocaine HCl)IBA
10/2013 - 06/2008

Therapy/Procedure

21Therapeutics
05/2022 - 09/2003
7Drug Therapy (Chemotherapy)
07/2018 - 01/2003
3Renal Dialysis (Hemodialysis)
01/2017 - 06/2003
2Organ Transplantation
12/2018 - 06/2003
2Transplantation
12/2017 - 11/2002